FDA Approves the HepQuant SHUNT® Liver Diagnostic Test to Quantify Risk of Large Esophageal Varices in Adult Patients with Compensated Cirrhosis (Child Pugh Class A)

DENVER--(BUSINESS WIRE)--The FDA has granted premarket approval (PMA) for the HepQuant SHUNT® Liver Diagnostic Test to aid in identifying patients unlikely to require EGD.